logo
Share SHARE
FONT-SIZE Plus   Neg

CytoDyn Appoints Nader Pourhassan As Interim CEO - Quick Facts

CytoDyn Inc. (CYDY: Quote) announced the appointment of Nader Pourhassan as its new interim Chief Executive Officer and Richard Trauger as its new Chief Scientific Officer.

Pourhassan brings over 20 years of advanced engineering and mathematics expertise as well as strong business acumen, to his new role. Prior to his new position as CEO, Pourhassan served as the Company's Managing Director of Business Development, and before that, as its Chief Operating Officer. He succeeds former President and CEO Kenneth Van Ness.

The appointment of Pourhassan to CEO follows the recent promotion of Richard Trauger from Managing Director of Science to Chief Scientific Officer on August 23, 2012.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
We are just a few weeks into 2015 and it has already been a busy year for merger deals and merger talks. Here is a list of some of the M&A stories that have made headlines so far in 2015. Diversified electronics maker TE Connectivity Ltd. is nearing a deal to sell its network solutions business unit to CommScope Holding Co., Inc. (COMM) in a deal valued at about $3 billion, according a Wall Street Journal report on Monday. A deal could be announced as early as this week. There has... The video game industry waltzed through 2014 with a record $24 billion in acquisitions and IPOs, says advisory firm Digi-Capital. The frenzied activity in the industry came as companies vied to get hold of game titles that could tilt the scale in their favor, and the need to shore up investment in infrastructure and marketing.
comments powered by Disqus
Follow RTT